Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 50S ribosomal subunit P-site (peptidyl site) is a fundamental component of the bacterial translation machinery, located within the large ribosomal subunit (Wilson, D. N., 2014, Nature Reviews Microbiology). Its primary biological role is to accommodate the tRNA molecule that carries the nascent polypeptide chain during protein synthesis (NCBI, 2023, Ribosome Structure). Positioned adjacent to the peptidyl transferase center (PTC), the P-site facilitates the transfer of the growing peptide to the aminoacyl-tRNA located in the A-site. This region is a major pharmacological target for several classes of antibiotics, including oxazolidinones like linezolid and pleuromutilins like lefamulin, which bind to the site to inhibit translation and arrest bacterial growth (StatPearls, 2023, Linezolid; FDA, 2019, Xenleta). While highly effective against a broad range of pathogens, drugs targeting this site must navigate the structural similarities between bacterial ribosomes and human mitochondrial ribosomes to avoid host toxicity, such as myelosuppression (NIH, 2022, LiverTox). Resistance mechanisms, such as mutations in the 23S rRNA or enzymatic modification by methyltransferases like Cfr, pose significant challenges to the long-term efficacy of therapies targeting this region (PubMed, 2016, Antibiotic Resistance).
Inhibition of bacterial protein synthesis by blocking the binding of peptidyl-tRNA or interfering with the peptidyl transferase center (PTC) activity (Wilson, D. N., 2014, Nature Reviews Microbiology).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 50S ribosomal subunit peptidyl-tRNA site (P-site) (50S P-site).